Robert Rifkin, MD, FACP, Attending Physician, Department of Cellular Therapy, Presbyterian/St. Luke’s Medical Center, regarding the role of proteasome inhibitors in maintenance therapy for multiple myeloma patients.
Role of Proteasome Inhibitors in MM
